Elutia (ELUT) Income from Continuing Operations (2019 - 2026)
Elutia (ELUT) posted Income from Continuing Operations of 7894000.0 for Q1 2026, down 149.26% sequentially from 3167000.0 in Q4 2025, and down 318.34% YoY from 3615528.64 in Q1 2025.
Elutia (ELUT) Income from Continuing Operations (2019 - 2026) Analysis & Trends
Elutia has reported Income from Continuing Operations for 8 years, with the latest figure at 7894000.0 in Q1 2026.
- Quarterly Income from Continuing Operations fell 318.34% year-over-year to 7894000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 21054000.0 (up 38.19% YoY) and the FY2025 annual result came in at 12528000.0, up 72.37% from the prior year.
- Income from Continuing Operations fell to 7894000.0 in Q1 2026 per ELUT's latest filing, from 3167000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 3339000.0 in Q3 2024 and troughed at 28360000.0 in Q2 2024.
- A 5-year average of 8762000.0 and a median of 8149000.0 in 2022 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2024 and 2026: Income from Continuing Operations soared 139.19% in 2024, then sank 318.34% in 2026.
- Over 5 years, Income from Continuing Operations stood at 6015000.0 in 2022, then slumped by 153.07% to 15222000.0 in 2023, then jumped by 53.0% to 7155000.0 in 2024, then jumped by 55.74% to 3167000.0 in 2025, then slumped by 149.26% to 7894000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 7894000.0, 3167000.0, and 383000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Elutia | 40.24 Mn | 20.35 Mn | 1.45 Mn | -7.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.89 Mn |
| Dec 31, 2025 | -3.17 Mn |
| Sep 30, 2025 | -383,000.00 |
| Jun 30, 2025 | -9.61 Mn |
| Mar 31, 2025 | -1.89 Mn |
| Dec 31, 2024 | -7.16 Mn |
| Sep 30, 2024 | 3.34 Mn |
| Jun 30, 2024 | -28.36 Mn |
| Mar 31, 2024 | -17.99 Mn |
| Dec 31, 2023 | -15.22 Mn |
| Sep 30, 2023 | -8.52 Mn |
| Jun 30, 2023 | -7.73 Mn |
| Mar 31, 2023 | -9.78 Mn |
| Dec 31, 2022 | -6.02 Mn |
| Sep 30, 2022 | -11.03 Mn |
| Jun 30, 2022 | -9.40 Mn |
| Mar 31, 2022 | -8.15 Mn |
| Dec 31, 2021 | -9.06 Mn |
| Sep 30, 2021 | -8.32 Mn |
| Jun 30, 2021 | -2.39 Mn |